InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: None

Friday, 10/23/2020 7:49:11 AM

Friday, October 23, 2020 7:49:11 AM

Post# of 402940
R fda approval is good for B.... only if B has a combo trial with R

IPIX is so far behind all the major players in terms of getting B approved for C through human trials

I find calls for compassionate use at this point humorous since no one has any more information on B for C than has been disseminated to date via PR - no one is going to be the guinea pig for B with promising in vitro results. There are so many other therapeutics out there claiming similar things to B in preclinical phases; even the Degrado pr hinted at this but the fact we are a synthetic makes us different. That's not a good enough reason to chose B over any other preclinical therapeutic

I was just talking with an ER doc from NYC that moved down to Florida and he was saying covid is just like the flu where someone would need annual covid shots just like the flu shot to prevent that year's strain of the virus. this is where therapeutics will shine, but something has got to give here

the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News